Newsfeeds - Spark Newswire

1 minute read

Events
News

MEI Pharma Shares Spike to Premarket High; Company Presents Today at AACR at 10 AM ET on their Treatment for AML

Today, 7:48 PM

Title: ME-344, a novel isoflavone mitochondrial inhibitor, in combination with venetoclax constitutes a new metabolism-targeted approach to overcome resistance to Bcl-2 inhibition and standard of care treatment in AML Authors: Katie Hurrish, et. al. Date: Wednesday, April 13, 2022, 10:00 AM – 1:30 PM ET AbstractID: 3785

MEIP

5 minute read

64 Biggest Movers From Friday

By Lisa Levin

Today, 7:48 PM

Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) shares surged 143% to settle at $3.84 on Friday after the company reported better-than-expected Q4 sales results and reaffirmed FY22 guidance.

AGFY

1 minute read

Analyst Ratings

Expert Ratings For MEI Pharma

By Benzinga Insights

Today, 7:48 PM

Analysts have provided the following ratings for MEI Pharma (NASDAQ:MEIP) within the last quarter:

MEIP

1 minute read

Analysts Cut Price Target On MEI Pharma As Stock Falls To 52-Week Low After Zandelisib Update

By Vandana Singh

Today, 7:48 PM

The FDA crushed MEI Pharma Inc's (NASDAQ: MEIP) hopes of winning accelerated approval for its PI3K inhibitor, zandelisib, on the strength of phase 2 data.

MEIP